FDA wants new study of lupus drug
Federal regulators said yesterday that they won&#39;t approve La Jolla Pharmaceutical&#39;s experimental lupus drug without an additional human study to prove its benefits.
Citing &quot;an urgent need&quot; at a time of flu vaccine shortages, Illinois asked for federal permission Monday to buy at least 62,000 vaccine doses from Europe for the state&#39;s nursing home residents.